Copyright Reports & Markets. All rights reserved.

Global Syndromic Diagnostic Test Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Syndromic Diagnostic Test by Type
    • 1.3.1 Overview: Global Syndromic Diagnostic Test Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Syndromic Diagnostic Test Consumption Value Market Share by Type in 2025
    • 1.3.3 Nucleic Acid Extraction Test
    • 1.3.4 Polymerase Chain Reaction (PCR) Test
    • 1.3.5 Others
  • 1.4 Global Syndromic Diagnostic Test Market by Application
    • 1.4.1 Overview: Global Syndromic Diagnostic Test Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Laboratory
    • 1.4.4 Research Institution
    • 1.4.5 Others
  • 1.5 Global Syndromic Diagnostic Test Market Size & Forecast
  • 1.6 Global Syndromic Diagnostic Test Market Size and Forecast by Region
    • 1.6.1 Global Syndromic Diagnostic Test Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Syndromic Diagnostic Test Market Size by Region, (2021-2032)
    • 1.6.3 North America Syndromic Diagnostic Test Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Syndromic Diagnostic Test Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Syndromic Diagnostic Test Market Size and Prospect (2021-2032)
    • 1.6.6 South America Syndromic Diagnostic Test Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Syndromic Diagnostic Test Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Abbott
    • 2.1.1 Abbott Details
    • 2.1.2 Abbott Major Business
    • 2.1.3 Abbott Syndromic Diagnostic Test Product and Solutions
    • 2.1.4 Abbott Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Abbott Recent Developments and Future Plans
  • 2.2 Hologic
    • 2.2.1 Hologic Details
    • 2.2.2 Hologic Major Business
    • 2.2.3 Hologic Syndromic Diagnostic Test Product and Solutions
    • 2.2.4 Hologic Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Hologic Recent Developments and Future Plans
  • 2.3 Applied BioCode
    • 2.3.1 Applied BioCode Details
    • 2.3.2 Applied BioCode Major Business
    • 2.3.3 Applied BioCode Syndromic Diagnostic Test Product and Solutions
    • 2.3.4 Applied BioCode Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Applied BioCode Recent Developments and Future Plans
  • 2.4 Danaher
    • 2.4.1 Danaher Details
    • 2.4.2 Danaher Major Business
    • 2.4.3 Danaher Syndromic Diagnostic Test Product and Solutions
    • 2.4.4 Danaher Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Danaher Recent Developments and Future Plans
  • 2.5 Diagenode
    • 2.5.1 Diagenode Details
    • 2.5.2 Diagenode Major Business
    • 2.5.3 Diagenode Syndromic Diagnostic Test Product and Solutions
    • 2.5.4 Diagenode Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Diagenode Recent Developments and Future Plans
  • 2.6 Curetis
    • 2.6.1 Curetis Details
    • 2.6.2 Curetis Major Business
    • 2.6.3 Curetis Syndromic Diagnostic Test Product and Solutions
    • 2.6.4 Curetis Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Curetis Recent Developments and Future Plans
  • 2.7 Bio-Rad
    • 2.7.1 Bio-Rad Details
    • 2.7.2 Bio-Rad Major Business
    • 2.7.3 Bio-Rad Syndromic Diagnostic Test Product and Solutions
    • 2.7.4 Bio-Rad Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Bio-Rad Recent Developments and Future Plans
  • 2.8 DiaSorin
    • 2.8.1 DiaSorin Details
    • 2.8.2 DiaSorin Major Business
    • 2.8.3 DiaSorin Syndromic Diagnostic Test Product and Solutions
    • 2.8.4 DiaSorin Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 DiaSorin Recent Developments and Future Plans
  • 2.9 bioMérieux
    • 2.9.1 bioMérieux Details
    • 2.9.2 bioMérieux Major Business
    • 2.9.3 bioMérieux Syndromic Diagnostic Test Product and Solutions
    • 2.9.4 bioMérieux Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 bioMérieux Recent Developments and Future Plans
  • 2.10 QIAGEN
    • 2.10.1 QIAGEN Details
    • 2.10.2 QIAGEN Major Business
    • 2.10.3 QIAGEN Syndromic Diagnostic Test Product and Solutions
    • 2.10.4 QIAGEN Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 QIAGEN Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Syndromic Diagnostic Test Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Syndromic Diagnostic Test by Company Revenue
    • 3.2.2 Top 3 Syndromic Diagnostic Test Players Market Share in 2025
    • 3.2.3 Top 6 Syndromic Diagnostic Test Players Market Share in 2025
  • 3.3 Syndromic Diagnostic Test Market: Overall Company Footprint Analysis
    • 3.3.1 Syndromic Diagnostic Test Market: Region Footprint
    • 3.3.2 Syndromic Diagnostic Test Market: Company Product Type Footprint
    • 3.3.3 Syndromic Diagnostic Test Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Syndromic Diagnostic Test Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Syndromic Diagnostic Test Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Syndromic Diagnostic Test Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Syndromic Diagnostic Test Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Syndromic Diagnostic Test Consumption Value by Type (2021-2032)
  • 6.2 North America Syndromic Diagnostic Test Market Size by Application (2021-2032)
  • 6.3 North America Syndromic Diagnostic Test Market Size by Country
    • 6.3.1 North America Syndromic Diagnostic Test Consumption Value by Country (2021-2032)
    • 6.3.2 United States Syndromic Diagnostic Test Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Syndromic Diagnostic Test Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Syndromic Diagnostic Test Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Syndromic Diagnostic Test Consumption Value by Type (2021-2032)
  • 7.2 Europe Syndromic Diagnostic Test Consumption Value by Application (2021-2032)
  • 7.3 Europe Syndromic Diagnostic Test Market Size by Country
    • 7.3.1 Europe Syndromic Diagnostic Test Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Syndromic Diagnostic Test Market Size and Forecast (2021-2032)
    • 7.3.3 France Syndromic Diagnostic Test Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Syndromic Diagnostic Test Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Syndromic Diagnostic Test Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Syndromic Diagnostic Test Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Syndromic Diagnostic Test Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Syndromic Diagnostic Test Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Syndromic Diagnostic Test Market Size by Region
    • 8.3.1 Asia-Pacific Syndromic Diagnostic Test Consumption Value by Region (2021-2032)
    • 8.3.2 China Syndromic Diagnostic Test Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Syndromic Diagnostic Test Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Syndromic Diagnostic Test Market Size and Forecast (2021-2032)
    • 8.3.5 India Syndromic Diagnostic Test Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Syndromic Diagnostic Test Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Syndromic Diagnostic Test Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Syndromic Diagnostic Test Consumption Value by Type (2021-2032)
  • 9.2 South America Syndromic Diagnostic Test Consumption Value by Application (2021-2032)
  • 9.3 South America Syndromic Diagnostic Test Market Size by Country
    • 9.3.1 South America Syndromic Diagnostic Test Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Syndromic Diagnostic Test Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Syndromic Diagnostic Test Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Syndromic Diagnostic Test Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Syndromic Diagnostic Test Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Syndromic Diagnostic Test Market Size by Country
    • 10.3.1 Middle East & Africa Syndromic Diagnostic Test Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Syndromic Diagnostic Test Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Syndromic Diagnostic Test Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Syndromic Diagnostic Test Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Syndromic Diagnostic Test Market Drivers
  • 11.2 Syndromic Diagnostic Test Market Restraints
  • 11.3 Syndromic Diagnostic Test Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Syndromic Diagnostic Test Industry Chain
  • 12.2 Syndromic Diagnostic Test Upstream Analysis
  • 12.3 Syndromic Diagnostic Test Midstream Analysis
  • 12.4 Syndromic Diagnostic Test Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Syndromic Diagnostic Test market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Syndromic diagnostic test is a type of medical test that enables the simultaneous detection and identification of multiple pathogens or disease markers associated with a specific syndrome or set of symptoms. Instead of targeting a single pathogen or condition, syndromic tests utilize advanced technologies like multiplex PCR, microarrays, or next-generation sequencing to identify a range of pathogens or genetic markers in a single analysis. These tests are particularly useful in situations where the exact cause of an illness is unknown or when there is a possibility of multiple disease agents contributing to the symptoms.
    This report is a detailed and comprehensive analysis for global Syndromic Diagnostic Test market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Syndromic Diagnostic Test market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Syndromic Diagnostic Test market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Syndromic Diagnostic Test market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Syndromic Diagnostic Test market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Syndromic Diagnostic Test
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Syndromic Diagnostic Test market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Hologic, Applied BioCode, Danaher, Diagenode, Curetis, Bio-Rad, DiaSorin, bioMérieux, QIAGEN, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Syndromic Diagnostic Test market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Nucleic Acid Extraction Test
    Polymerase Chain Reaction (PCR) Test
    Others
    Market segment by Application
    Hospital
    Laboratory
    Research Institution
    Others
    Market segment by players, this report covers
    Abbott
    Hologic
    Applied BioCode
    Danaher
    Diagenode
    Curetis
    Bio-Rad
    DiaSorin
    bioMérieux
    QIAGEN
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Syndromic Diagnostic Test product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Syndromic Diagnostic Test, with revenue, gross margin, and global market share of Syndromic Diagnostic Test from 2021 to 2026.
    Chapter 3, the Syndromic Diagnostic Test competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Syndromic Diagnostic Test market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Syndromic Diagnostic Test.
    Chapter 13, to describe Syndromic Diagnostic Test research findings and conclusion.

    Buy now